Menstrual disorders in women with epilepsy

Neurology

Volumn 66, Issue 6 SUPPL. 3, 2006, Pages

  Herzog, Andrew G ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; SEX HORMONE; VALPROIC ACID; ANTIDEPRESSANT AGENT;

ANOVULATION; CANCER; EMOTIONAL DISORDER; EPILEPSY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERANDROGENISM; INFERTILITY; MENOPAUSE; MENSTRUATION DISORDER; MIGRAINE; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATIENT CARE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; AGE; GONADAL DISEASE; HORMONE SUBSTITUTION; METHODOLOGY; SEXUAL DEVELOPMENT;

AGE FACTORS; ANTIDEPRESSIVE AGENTS; EPILEPSY; FEMALE; GONADAL DISORDERS; HORMONE REPLACEMENT THERAPY; HUMANS; MENSTRUATION DISTURBANCES; SEX CHARACTERISTICS;

EID: 33645737195     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.66.66_suppl_3.s23     Document Type: Review

References (54)

1. Herzog AG, Fowler KM. Sexual hormones and epilepsy: threat and opportunities. Curr Opin Neurol 2005;18:167-172.
2. Isojärvi JIT, Taubøll E, Herzog AG. Effects of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy - a review. CNS Drugs 2005;19:207-223.
3. Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2001;57:2133-2135.
4. Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Obstet Gynecol 1978;51:97-101.
5. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976;54:321-347.
6. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082-1088.
7. Marcus EM, Watson CW, Goldman PL. Effects of steroids on cerebral electrical activity. Arch Neurol 1966;15:521-532.
8. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986;232:1004-1007.
9. Wong M, Moss R. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci 1992;12:3217-3225.
10. Logothetis J, Harner R, Morrell F, Torres F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959;9:352-360.
11. Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995;45:1660-1662.
12. Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999;52:1917-1918.
13. Herzog AG, Schachter SC. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 2001;42:311-315.
14. Herzog AG, Coleman AE, Jacobs AR, et al. Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Ann Neurol 2003;54:625-637.
15. Svalheim S, Taubøll E, Bjørnenak T, et al. Do women with epilepsy have increased frequency of menstrual disturbances? Seizure 2003;12:529-533.
16. Morrell MJ, Giudice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002;52:704-711.
17. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986;43:341-346.
18. Herzog AG. A hypothesis to integrate partial seizures of temporal lobe origin and reproductive endocrine disorders. Epilepsy Res 1989;3:151-159.
19. Bilo L, Meo R, Nappi C, et al. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 1988;29:612-619.
20. Bilo L, Meo R, Valentino R, Buscaino GA, Striano S, Nappi C. Abnormal patterns of luteinizing hormone pulsatility in women with epilepsy. Fertil Steril 1991;55:705-711.
21. Herzog AG. A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy. Neurology 1993;43:1907-1910.
22. Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia 2003;44(suppl 4):11-20.
23. Morrell MJ, Flynn KL, Seale CG, et al. Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones. CNS Spectrums 2001;6:771-786.
24. Taubøll E, Isojärvi JIT, Flinstad Harbo H, Pakarinen AJ, Gjerstad L. Effects of long-term valproate treatment on serum sex steroid hormone levels and ovarian morphology in female wistar rats. Seizure 1999;8:490-493.
25. Røste LS, Taubøll E, Berner A, Isojärvi JIT, Gjerstad L. Valproate, but not lamotrigine, induces ovarian morphological changes in Wistar rats. Exp Toxicol Pathol 2001;52:545-552.
26. Gerendai I, Csaba Z, Voko Z, Csernus V. Involvement of a direct neural mechanism in the control of gonadal functions. J Steroid Biochem Mol Biol 1995;53:299-305.
27. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-1388.
28. Lobo RA. A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS," what are we to call it? Fertil Steril 1995;63:1158-1160.
29. Murialdo G, Galimberti CA, Magri F, et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest 1997;20:519-526.
30. Murialdo G, Galimberti CA, Gianelli MV, et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998;21:52-58.
31. Betts T, Yarrow H, Dutton N, Greenhill L, Rolfe T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure 2003;12:323-329.
32. Isojärvi JIT, Rättyä J, Myllylä VV, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-451.
33. Ferin M, Morrell M, Xiao E, et al. Endocrine and metabolic responses to long-term monotherapy with the antiepileptic drug valproate in the normally cycling rhesus monkey. J Clin Endocrinol Metab 2003;88:2908-2915.
34. Rasgon NL, Altshuler LL, Gudeman D, et al. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry 2000;61:173-178.
35. O'Donovan C, Kusumakar V, Graves GR, Bird DC. Menstrual abnormalities in women taking valproate for bipolar mood disorder. J Clin Psychiatry 2002;63:322-330.
36. Akdeniz F, Taneli F, Noyan A, Yüncü Z, Vahip S. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? Prog Neuropsychopharmacol Biol Psychiatry 2003;27:115-121.
37. Herzog AG. Polycystic ovarian syndrome in women with epilepsy: epileptogenic or iatrogenic? Ann Neurol 1996;39:559-560.
38. Eagleson CA, Gingrich MB, Pastor CL, et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab 2000;85:4047-4052.
39. Taubøll E, Gregoraszczuk EL, Kolodziej A, Kajta M, Ropstad E. Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia 2003;44:1014-1021.
40. Docke F, Moldenhauer U, Rohde W, Dorner G. [Animal experimental studies on the neurohormonal control of female puberty. 3. The effect of the mediocortical amygdala on the maturation of the positive estrogen feedback] Tierexperimentelle Untersuchungen zur neurohormonalen Kontrolle der weiblichen Pubertat. Zentralbl Gynakol 1978;100:931-941.
41. Zolovick AJ. Effects of lesions and electrical stimulation of the amygdala on hypothalamic-hypophyseal regulation. In: Eleftheriou BE, ed. The neurobiology of the amygdala. New York: Plenum Press, 1972:745-762.
42. Edwards HE, Burnham WM, Ng MM, Asa S, MacLusky NJ. Limbic seizures alter reproductive function in the female rat. Epilepsia 1999;40:1370-1377
43. Diamontopoulos N, Crumrine PK. The effect of puberty on the course of epilepsy. Arch Neurol 1986;43:873-876.
44. Rättyä J, Vainionpää L, Knip M, Lanning P, Isojävi JIT. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics 1999;103:588-593.
45. Mikkonen K, Vainionpää LK, Pakarinen AJ, et al. Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 2004;62:445-450.
46. Klein P, Serje A, Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001;42:1584-1589.
47. Harden CL, Koppel BS, Herzog AG, Nikolov BG, Hauser WA. Seizure frequency is associated with age of menopause in women with epilepsy. Neurology 2003;61:451-455.
48. Turner WA. Epilepsy: a study of the idiopathic disease. London: MacMillan, 1907.
49. Woolley DE, Timiras PS. The gonad-brain relationship: effects of female sex hormones on electroshock convulsions in the rat. Endocrinology 1962;70:196-209.
50. Sallusto L, Pozzi O. Relations between ovarian activity and the occurrence of epileptic seizures: data on a clinical case. Acta Neurol (Napoli) 1964;19:673-681.
51. Abbasi F, Krumholz A, Kittner SJ, Langenberg P. Effects of menopause on seizures in women with epilepsy. Epilepsia 1999;40:205-210.
52. Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999;40:1402-1407.
53. Harden CL, Nikolov B, Labar D, Herzog A, Fowler K, Hauser W. Effects of hormone replacement on seizure frequency in menopausal women with epilepsy. Epilepsia 2004;45:230-231.
54. Harden CL, Koppel BS, Herzog AG, et al. Hormone replacement therapy in menopausal women with epilepsy. Ann Neurol 2006. In press.